{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:57:34Z","timestamp":1772557054328,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s10120-025-01708-5","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T11:44:09Z","timestamp":1767786249000},"page":"376-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Definitive 24\u00a0Gy radiotherapy for stage IE gastric MALT lymphoma: large-scale validation of an optimal dose with reduced acute toxicity"],"prefix":"10.1007","volume":"29","author":[{"given":"Jong Yun","family":"Baek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5426-0604","authenticated-orcid":false,"given":"Do Hoon","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun Haeng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Hoon","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"1708_CR1","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1053\/j.gastro.2005.03.083","volume":"128","author":"P Farinha","year":"2005","unstructured":"Farinha P, Gascoyne RD. Helicobacter pylori and MALT lymphoma. Gastroenterology. 2005;128:1579\u2013605.","journal-title":"Gastroenterology"},{"key":"1708_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","volume":"31","author":"E Zucca","year":"2020","unstructured":"Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, et al. Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:17\u201329.","journal-title":"Ann Oncol"},{"key":"1708_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","volume":"8","author":"A Zullo","year":"2010","unstructured":"Zullo A, Hassan C, Cristofari F, Andriani A, De Francesco V, Ierardi E, et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 2010;8:105\u201310.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1708_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/gutjnl-2011-300495","volume":"61","author":"S Nakamura","year":"2012","unstructured":"Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut. 2012;61:507\u201313.","journal-title":"Gut"},{"key":"1708_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1200\/OP.23.00624","volume":"20","author":"C Laoruangroj","year":"2024","unstructured":"Laoruangroj C, Habermann TM, Wang Y, King RL, Lester SC, Thompson CA, et al. Should all patients with stage IE gastric Mucosa-Associated lymphoid tissue lymphoma receive antibiotic eradication therapy for Helicobacter pylori? JCO Oncol Pract. 2024;20:1103\u20138.","journal-title":"JCO Oncol Pract"},{"key":"1708_CR6","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.ijrobp.2020.03.019","volume":"107","author":"A Wirth","year":"2020","unstructured":"Wirth A, Mikhaeel NG, Aleman BMP, Pinnix CC, Constine LS, Ricardi U, et al. Involved site radiation therapy in adult lymphomas: an overview of international lymphoma radiation oncology group guidelines. Int J Radiat Oncol Biol Phys. 2020;107:909\u201333.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1708_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","volume":"92","author":"J Yahalom","year":"2015","unstructured":"Yahalom J, Illidge T, Specht L, Hoppe RT, Li YX, Tsang R, et al. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the international lymphoma radiation oncology group. Int J Radiat Oncol Biol Phys. 2015;92:11\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1708_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.radonc.2015.08.029","volume":"117","author":"A Ruskone-Fourmestraux","year":"2015","unstructured":"Ruskone-Fourmestraux A, Matysiak-Budnik T, Fabiani B, Cervera P, Brixi H, Le Malicot K, et al. Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: results of a prospective study with a long term follow-up. Radiother Oncol. 2015;117:178\u201382.","journal-title":"Radiother Oncol"},{"key":"1708_CR9","doi-asserted-by":"publisher","first-page":"570","DOI":"10.4143\/crt.2024.651","volume":"57","author":"JU Jeong","year":"2025","unstructured":"Jeong JU, Lee HC, Song JH, Eom KY, Kim JH, Kwak YK, et al. Long-term clinical efficacy of radiotherapy for patients with stage I-II gastric extranodal marginal zone B-Cell lymphoma of Mucosa-Associated lymphoid tissue: A retrospective Multi-institutional study. Cancer Res Treat. 2025;57:570\u20139.","journal-title":"Cancer Res Treat"},{"key":"1708_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ijrobp.2019.02.002","volume":"104","author":"CC Pinnix","year":"2019","unstructured":"Pinnix CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, et al. Outcomes after Reduced-Dose intensity modulated radiation therapy for gastric Mucosa-Associated lymphoid tissue (MALT) lymphoma. Int J Radiat Oncol Biol Phys. 2019;104:447\u201355.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1708_CR11","doi-asserted-by":"publisher","first-page":"100714","DOI":"10.1016\/j.adro.2021.100714","volume":"6","author":"O Saifi","year":"2021","unstructured":"Saifi O, Lester SC, Rule W, Stish BJ, Stafford S, Pafundi DH, et al. Comparable efficacy of reduced dose radiation therapy for the treatment of early stage gastric extranodal marginal zone lymphoma of Mucosa-Associated lymphoid tissue. Adv Radiat Oncol. 2021;6:100714.","journal-title":"Adv Radiat Oncol"},{"key":"1708_CR12","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.ijrobp.2024.10.020","volume":"121","author":"SH Jeon","year":"2025","unstructured":"Jeon SH, Chang JH, Kim IH, Yoon HI, Eom KY. Reduced-dose radiation therapy for stage IE gastric Mucosa-Associated lymphoid tissue lymphoma: A Multi-Institutional prospective study (KROG 16\u201318). Int J Radiat Oncol Biol Phys. 2025;121:1000\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1708_CR13","unstructured":"NCCN Clinical Practice Guidelines in Oncology: B-Cell Lymphomas. 2025. (Accessed August 24, 2025, at https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf.)."},{"key":"1708_CR14","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32:3059\u201368.","journal-title":"J Clin Oncol"},{"key":"1708_CR15","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/oxfordjournals.annonc.a058869","volume":"5","author":"A Rohatiner","year":"1994","unstructured":"Rohatiner A, d\u2019Amore F, Coiffier B, Crowther D, Gospodarowicz M, Isaacson P, et al. Report on a workshop convened to discuss the pathological and staging classifications of Gastrointestinal tract lymphoma. Ann Oncol. 1994;5:397\u2013400.","journal-title":"Ann Oncol"},{"issue":"Suppl 5","key":"1708_CR16","doi-asserted-by":"publisher","first-page":"v175","DOI":"10.1093\/annonc\/mdq182","volume":"21","author":"E Zucca","year":"2010","unstructured":"Zucca E, Dreyling M, Group EGW. Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v175\u20136.","journal-title":"Ann Oncol"},{"key":"1708_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/cancers13020169","volume":"13","author":"H Nam","year":"2021","unstructured":"Nam H, Lim DH, Kim JJ, Lee JH, Min BH, Lee H. Long-Term clinical outcome and predictive factors for relapse after radiation therapy in 145 patients with stage I gastric B-Cell lymphoma of Mucosa-Associated lymphoid tissue type. Cancers (Basel). 2021;13:169.","journal-title":"Cancers (Basel)"},{"key":"1708_CR18","doi-asserted-by":"publisher","first-page":"6062","DOI":"10.3748\/wjg.v19.i36.6062","volume":"19","author":"SW Kim","year":"2013","unstructured":"Kim SW, Lim DH, Ahn YC, Kim WS, Kim SJ, Ko YH, et al. Clinical outcomes of radiation therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma. World J Gastroenterol. 2013;19:6062\u20138.","journal-title":"World J Gastroenterol"},{"key":"1708_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejphar.2013.09.069","volume":"722","author":"P Feyer","year":"2014","unstructured":"Feyer P, Jahn F, Jordan K. Radiation induced nausea and vomiting. Eur J Pharmacol. 2014;722:165\u201371.","journal-title":"Eur J Pharmacol"},{"key":"1708_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3748\/wjg.v19.i2.185","volume":"19","author":"AK Shadad","year":"2013","unstructured":"Shadad AK, Sullivan FJ, Martin JD, Egan LJ. Gastrointestinal radiation injury: symptoms, risk factors and mechanisms. World J Gastroenterol. 2013;19:185\u201398.","journal-title":"World J Gastroenterol"},{"key":"1708_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4143\/crt.2021.073","volume":"54","author":"JY Baek","year":"2022","unstructured":"Baek JY, Lim DH, Oh D, Nam H, Kim JJ, Lee JH, et al. Increased risk of diabetes after definitive radiotherapy in patients with indolent gastroduodenal lymphoma. Cancer Res Treat. 2022;54:294\u2013300.","journal-title":"Cancer Res Treat"},{"key":"1708_CR22","doi-asserted-by":"publisher","first-page":"4110","DOI":"10.3390\/cancers14174110","volume":"14","author":"J Lee","year":"2022","unstructured":"Lee J, Yoon HI, Kim J, Cho J, Kim KH, Suh CO. Risk of diabetes mellitus after radiotherapy for gastric Mucosa-Associated lymphoid tissue lymphoma. Cancers (Basel). 2022;14:4110.","journal-title":"Cancers (Basel)"},{"key":"1708_CR23","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41416-018-0248-x","volume":"119","author":"HJ Groot","year":"2018","unstructured":"Groot HJ, Gietema JA, Aleman BMP, Incrocci L, de Wit R, Witjes JA, et al. Risk of diabetes after para-aortic radiation for testicular cancer. Br J Cancer. 2018;119:901\u20137.","journal-title":"Br J Cancer"},{"key":"1708_CR24","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1200\/JCO.2013.54.4379","volume":"32","author":"FA van Nimwegen","year":"2014","unstructured":"van Nimwegen FA, Schaapveld M, Janus CP, Krol AD, Raemaekers JM, Kremer LC, et al. Risk of diabetes mellitus in long-term survivors of hodgkin lymphoma. J Clin Oncol. 2014;32:3257\u201363.","journal-title":"J Clin Oncol"},{"key":"1708_CR25","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1470-2045(12)70323-6","volume":"13","author":"F de Vathaire","year":"2012","unstructured":"de Vathaire F, El-Fayech C, Ben Ayed FF, Haddy N, Guibout C, Winter D, et al. Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study. Lancet Oncol. 2012;13:1002\u201310.","journal-title":"Lancet Oncol"},{"key":"1708_CR26","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/archinternmed.2009.209","volume":"169","author":"LR Meacham","year":"2009","unstructured":"Meacham LR, Sklar CA, Li S, Liu Q, Gimpel N, Yasui Y, et al. Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch Intern Med. 2009;169:1381\u20138.","journal-title":"Arch Intern Med"},{"key":"1708_CR27","unstructured":"Baek JY, Lim DH, Oh D, Kim JJ, Lee JH, Min BH et al. Pancreatic irradiation dose as a risk factor for elevation in hemoglobin A1c level and diabetes mellitus in patients with indolent gastroduodenal lymphoma. Cancer Res Treat. 2025."},{"key":"1708_CR28","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1016\/S2352-3026(24)00133-9","volume":"11","author":"JR Gunther","year":"2024","unstructured":"Gunther JR, Xu J, Bhutani MS, Strati P, Fang PQ, Wu SY, et al. Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial. Lancet Haematol. 2024;11:e521\u20139.","journal-title":"Lancet Haematol"},{"key":"1708_CR29","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/annonc\/mds623","volume":"24","author":"A Wirth","year":"2013","unstructured":"Wirth A, Gospodarowicz M, Aleman BM, Bressel M, Ng A, Chao M, et al. Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, international extranodal lymphoma study group study. Ann Oncol. 2013;24:1344\u201351.","journal-title":"Ann Oncol"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01708-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-025-01708-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-025-01708-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:00:28Z","timestamp":1772550028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-025-01708-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1708"],"URL":"https:\/\/doi.org\/10.1007\/s10120-025-01708-5","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board (IRB) of Samsung Medical Center (approval number: 2025-07-087) and conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. The Institutional Review Board waived the requirement for signed informed consent from the patients or their guardians owing to the retrospective nature of the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. This study is a retrospective analysis approved by the IRB of Samsung Medical Center. No identifiable personal data, images, or videos of individual participants are included in this manuscript, and patient anonymity has been fully maintained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}